栖息地
发表于 2025-3-28 16:20:45
Novel Assay Technologies for the Discovery of G Protein-Coupled Receptor Drugs
不要不诚实
发表于 2025-3-28 21:37:33
http://reply.papertrans.cn/64/6323/632266/632266_42.png
fledged
发表于 2025-3-29 00:27:14
Quantifying Allosteric Modulation of G Protein-Coupled Receptors
FATAL
发表于 2025-3-29 03:20:30
http://reply.papertrans.cn/64/6323/632266/632266_44.png
使增至最大
发表于 2025-3-29 09:23:55
Methods for the Discovery and Characterization of G Protein-Coupled Receptors
冷漠
发表于 2025-3-29 15:22:30
http://reply.papertrans.cn/64/6323/632266/632266_46.png
Addictive
发表于 2025-3-29 17:23:53
http://reply.papertrans.cn/64/6323/632266/632266_47.png
Explosive
发表于 2025-3-29 20:18:45
http://reply.papertrans.cn/64/6323/632266/632266_48.png
BOOR
发表于 2025-3-30 02:54:08
http://reply.papertrans.cn/64/6323/632266/632266_49.png
Thyroxine
发表于 2025-3-30 08:08:27
Dmitri Proudnikov,Vadim Yuferov,Mary Jeanne Kreekrity of these strokes are ischemic, primarily caused by intracranial atherosclerosis. Most therapies to combat intracranial atherosclerosis simply manage it and do not remove the buildup of plaque. Targeted shear-activated nano-therapeutics are currently being developed to remove these plaques. We d